Skip to content

Clinical trials

Lymphoma, B-Cell, Marginal Zone trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Phase: Not applicable Country / region: United States Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20022
20035
20043
20053
20063
20072
20081
20093
20103
20112
20141
20151
20162
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Terminated14
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center9
Roswell Park Cancer Institute4
City of Hope Medical Center3
Masonic Cancer Center, University of Minnesota3
Barbara Ann Karmanos Cancer Institute2
Case Comprehensive Cancer Center2
National Cancer Institute (NCI)2
OHSU Knight Cancer Institute2
Wake Forest University Health Sciences2
Astex Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone44
Lymphoma, Follicular44
Leukemia, Lymphocytic, Chronic, B-Cell43
Burkitt Lymphoma40
Lymphoma, Mantle-Cell40
Lymphoma, Non-Hodgkin40
Precursor Cell Lymphoblastic Leukemia-Lymphoma40
Lymphoma, Large B-Cell, Diffuse39
Lymphoma, Large-Cell, Immunoblastic37
Hodgkin Disease34

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.